How Good Is Mercialys (EPA:MERY), When It Comes To ROE?

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Equity (ROE). We'll use ROE to examine Mercialys (EPA:MERY), by way of a worked example.

Over the last twelve months Mercialys has recorded a ROE of 10%. One way to conceptualize this, is that for each €1 of shareholders' equity it has, the company made €0.10 in profit.

See our latest analysis for Mercialys

Advertisement

How Do I Calculate ROE?

The formula for ROE is:

Return on Equity = Net Profit ÷ Shareholders' Equity

Or for Mercialys:

10% = €82m ÷ €892m (Based on the trailing twelve months to June 2018.)

It's easy to understand the 'net profit' part of that equation, but 'shareholders' equity' requires further explanation. It is the capital paid in by shareholders, plus any retained earnings. The easiest way to calculate shareholders' equity is to subtract the company's total liabilities from the total assets.

What Does Return On Equity Signify?

Return on Equity measures a company's profitability against the profit it has kept for the business (plus any capital injections). The 'return' is the profit over the last twelve months. That means that the higher the ROE, the more profitable the company is. So, all else being equal, a high ROE is better than a low one. That means it can be interesting to compare the ROE of different companies.

Does Mercialys Have A Good Return On Equity?

Arguably the easiest way to assess company's ROE is to compare it with the average in its industry. Importantly, this is far from a perfect measure, because companies differ significantly within the same industry classification. The image below shows that Mercialys has an ROE that is roughly in line with the reits industry average (9.4%).

ENXTPA:MERY Last Perf November 9th 18
ENXTPA:MERY Last Perf November 9th 18

That's neither particularly good, nor bad. ROE can change from year to year, based on decisions that have been made in the past. So I like to check the tenure of the board and CEO, before reaching any conclusions.

Why You Should Consider Debt When Looking At ROE

Virtually all companies need money to invest in the business, to grow profits. That cash can come from retained earnings, issuing new shares (equity), or debt. In the case of the first and second options, the ROE will reflect this use of cash, for growth. In the latter case, the debt used for growth will improve returns, but won't affect the total equity. Thus the use of debt can improve ROE, albeit along with extra risk in the case of stormy weather, metaphorically speaking.

Mercialys's Debt And Its 10% ROE

It's worth noting the significant use of debt by Mercialys, leading to its debt to equity ratio of 2.10. while its ROE is respectable, it is worth keeping in mind that there is usually a limit to how much debt a company can use. Debt does bring some extra risk, so it's only really worthwhile when a company generates some decent returns from it.

The Key Takeaway

Return on equity is useful for comparing the quality of different businesses. Companies that can achieve high returns on equity without too much debt are generally of good quality. All else being equal, a higher ROE is better.

But when a business is high quality, the market often bids it up to a price that reflects this. The rate at which profits are likely to grow, relative to the expectations of profit growth reflected in the current price, must be considered, too. So you might want to take a peek at this data-rich interactive graph of forecasts for the company.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this freelist of interesting companies.

To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.

The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at editorial-team@simplywallst.com.

Simply Wall St analyst Simply Wall St and Simply Wall St have no position in any of the companies mentioned. This article is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

MI
mitchell_lawler
mitchell_lawler

Moderna nearly tripled overnight, and every other mRNA stock jumped with it. I think that could be a trap.

Moderna nearly tripled overnight, and every other mRNA stock jumped with it. I think that could be a trap. cover
1910
PR
pri_dlp7z

Happy for the melanoma patients. It is no surprise that other companies moved up too. It's the optionality getting priced in.

About ENXTPA:MERY

Mercialys

Mercialys SA is one of France’s leading real estate companies.

Reasonable growth potential average dividend payer.

Advertisement

Weekly Picks

RI
Rick_Orford
FJET logo
Rick_Orford on Starfighters Space ·

The 1960s Fighter Jet That Could Crack Open a $20 Billion Satellite Market

Fair Value:US$520.4% undervalued
56 users have followed this narrative
3 users have commented on this narrative
7 users have liked this narrative
JO
John_Eric
MELI logo
John_Eric on MercadoLibre ·

MercadoLibre and the Spreadsheet Trick That Decides Everything

Fair Value:US$7.31k73.7% undervalued
102 users have followed this narrative
2 users have commented on this narrative
16 users have liked this narrative
RC
PYPL logo
rcb9 on PayPal Holdings ·

Ten Percent More Volume, One Percent More Transaction Margin

Fair Value:US$70.8912.1% undervalued
15 users have followed this narrative
1 users have commented on this narrative
6 users have liked this narrative
HE
HedgeY
MU logo
HedgeY on Micron Technology ·

Micron - The Memory Bottleneck Behind the AI Supercycle

Fair Value:US$1.25k22.1% undervalued
40 users have followed this narrative
0 users have commented on this narrative
13 users have liked this narrative

Updated Narratives

TA
TanishTrivedi
KPITTECH logo
TanishTrivedi on KPIT Technologies ·

KPITTECH: A Thesis for Patient Capital

Fair Value:₹719.9117.6% undervalued
15 users have followed this narrative
0 users have commented on this narrative
1 users have liked this narrative
CH
IRB logo
chi_17 on IRB Infrastructure Developers ·

IRB Infrastructure Developers Is Set to Boost Revenue with a 26% Surge on YoY toll collection

Fair Value:₹2832.3% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
DA
CSL logo
danmad on CSL ·

Strong buy. World-leading healthcare company with steady growth

Fair Value:AU$21018.5% undervalued
28 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28022.6% undervalued
335 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9114.6% overvalued
185 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
KI
AMZN logo
KiwiInvest on Amazon.com ·

Amazon's high growth, high tech segments propel its profits, while traditional segments plod along

Fair Value:US$475.0945.3% undervalued
213 users have followed this narrative
1 users have commented on this narrative
8 users have liked this narrative

Trending Discussion

MA
MRNA logo
Madave on Moderna ·

Aged like wine

2
|
0
QU
QuanD
MRNA logo
QuanD on Moderna ·

Did you get a crystal ball?

1
|
0